<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>300</height>
  <width>600</width>
  <title>Antiplatelets After ASCVD: Less Autopilot, More Judgment 🧭</title>
  <description>🩸 Antiplatelet therapy is no longer “aspirin for all” or “DAPT by habit.” The 2026 ACC Scientific Statement reframes care around precision: ischemic risk, bleeding risk, PCI/ACS context, PAD or stroke phenotype, surgery, anticoagulation, and adherence. The modern message: choose the right agent, right intensity, and right duration—then reassess. Platelets may be small, but the decisions are not. ⚖️🔬 Source: 2026 ACC Scientific Statement on antiplatelet therapy. </description>
  <author_name>Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!</author_name>
  <author_url>http://www.MasterMedFacts.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41947025/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/203721670</thumbnail_url>
</oembed>
